Axilla-conserving therapy in breast cancer patients after neoadjuvant systemic therapy: a literature review
10.3760/cma.j.cn113030-20230809-00043
- VernacularTitle:乳腺癌新辅助全身治疗后保留腋窝的研究进展
- Author:
Zihan QIU
1
;
Shulian WANG
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科，北京 100021
- Keywords:
Breast neoplasms;
Neoadjuvant systemic therapy;
Sentinel lymph node biopsy
- From:
Chinese Journal of Radiation Oncology
2024;33(7):661-667
- CountryChina
- Language:Chinese
-
Abstract:
With the development of effective neoadjuvant systemic therapy for breast cancer, there is a trend towards reducing the surgical treatment intensity and conserving the axilla. It is possible to omit axillary lymph node dissection for patients with axillary downstaging after neoadjuvant systemic therapy. However, whether axillary radiotherapy can replace axillary lymph node dissection remains to be further studied. The complete omission of axillary surgery is also the focus of clinical research for patients who can be predicted to achieve axillary pathological complete response. In this article, we provide an overview of recent research progress in axilla-conserving therapy for breast cancer patients after neoadjuvant systemic therapy.
